# Lyell Immunopharma, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/lyell-immunopharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 17 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-13T04:46:30.796235+00:00 | | Last reviewed | 2026-09-13T04:46:30.796235+00:00 | ## Identity - Legal name: Lyell Immunopharma, Inc. - Display name: Lyell Immunopharma, Inc. ## Leadership - Clifford J. Friedman: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2. - Elizabeth Nabel: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2. - Lynn Seely, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2. - Martine Rothblatt, Ph.D., J.D., M.B.A.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2. - Otis Brawley, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2. - Richard Klausner, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2. - Sumant Ramachandra, M.D., Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2. - William Rieflin: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2. - David Shook, M.D.: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:3. - Gary Lee, Ph.D.: Chief Scientific Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:3. - Lynn Seely, M.D.: President, Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:3. - Mark Meltz: General Counsel and Corporate Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:3. - Smital Shah: Chief Financial and Business Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:3. - Stephen Hill: Chief Operating Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Lyell Immunopharma, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:1. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/lyell-immunopharma-inc). - alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:2: [Lyell Immunopharma, Inc. DEF 14A 2026-04-24](https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm). - alpha:evidence:company:c4cef1ca-c5d7-4446-8c3a-0cd3753768fb:3: [LYEL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/lyell-immunopharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/lyell-immunopharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/lyell-immunopharma-inc) - [JSON-LD](https://registry.alpha.ac/api/public/companies/lyell-immunopharma-inc?format=jsonld) - MCP resource: `alpha://companies/lyell-immunopharma-inc` at https://mcp.alpha.ac/mcp